← All patents

US10729781B2

LGR4 specific monoclonal antibodies and methods of their use

University of Texas System

Abstract

Isolated or recombinant anti-LGR4 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Qingyun Liu
Priority date
December 15, 2015
Filing date
December 09, 2016
Grant date
August 04, 2020
Publication date
August 04, 2020
Language
en
Metadata fetched
August 29, 2026 00:27